Abstract. Excessive tau protein phosphorylation is important in the pathogenesis and early abnormal signal transduction of Alzheimer's disease. Excessive phosphorylation of micro- tubules is associated with tau accumulation, which induces the formation of neurofibrillary tangles in neurons, leading
Ying Yao,Xianchun Chen,Wu Yangsheng,Y. Bao
Abstract:Excessive tau protein phosphorylation is important in the pathogenesis and early abnormal signal transduction of Alzheimer's disease. Excessive phosphorylation of microtubules is associated with tau accumulation, which induces the formation of neurofibrillary tangles in neurons, leading to synaptic damage and ultimately, neurodegeneration. The present study aimed to investigate the possible mechanism underlying the inhibitory effects of puerarin on β-amyloid peptide (Aβ)1-42-induced tau protein hyperphosphorylation in SH-SY5Y cells. Following various treatments, the viability of SH-SY5Y cells was determined using the MTT assay, and cell morphology was observed under an inverted fluorescence microscope. Western blotting was used to detect tau phosphorylation, and the protein expression levels of glycogen synthase kinase (GSK)-3β, phosphorylated (p)-GSK-3β (Ser9), β-catenin and cyclin D1, which are the key factors mediating the Wnt/β-catenin signaling pathway in SH-SY5Y cells. The results demonstrated that puerarin reversed the Aβ1-42-induced decrease in SH-SY5Y cell viability. In addition, puerarin inhibited the degree of Aβ1-42-induced tau phosphorylation at Ser396, Ser199 and Thr231 in SH-SY5Y cells, and reduced the expression of GSK-3β by increasing the expression of p-GSK-3β (Ser9). Furthermore, puerarin increased the protein expression levels of β-catenin and cyclin D1, which are key factors involved in the Wnt/β-catenin signaling pathway. The results of the present study demonstrated that puerarin may attenuate Aβ1-42-induced tau hyperphosphorylation in SH-SY5Y cells, by inhibiting the expression of GSK-3β and activating the Wnt/β-catenin signaling pathway; therefore, puerarin may exert protective effects against Alzheimer's disease. Introduction Alzheimer's disease (AD), also known as senile dementia, is a degenerative disease of the central nervous system that is predominantly characterized by progressive degeneration of cognitive function and memory loss. Previous studies have suggested that disorders of the Wnt/β-catenin signaling pathway in the brains of patients with AD may be associated with pathological alterations (1,2), including formation of neurofibrillary tangles (NFTs) involving neurites and phosphorylated tau proteins, and neuronal loss and senile plaques triggered by β-amyloid peptide (Aβ) accumulation. The Wnt/β-catenin signaling pathway may therefore be considered the core pathway linking Aβ neurotoxicity with tau hyperphosphorylation. Glycogen synthase kinase (GSK)-3β is a multifunctional serine/threonine kinase and a negative regulator of Wnt/β-catenin signaling. Its abnormal expression is closely associated with the pathogenesis, pathological manifestations and treatment of AD (2). Previous studies have suggested that GSK-3β is a protein kinase that may induce abnormal tau phosphorylation in the brains of patients with AD and phosphorylation of tau at numerous sites (3,4). Puerarin is the main active ingredient derived from the Chinese herb root of Pueraria lobata, which is a selective inhibitor of GSK-3β (5,6). Previous research has indicated that puerarin downregulates Aβ expression in the brain, inhibits the abnormal expression of tau protein induced by Aβ, reduces cellular apoptosis, and improves learning and memory in animals (7-10). Puerarin exhibits anti-AD activity by inhibiting the activity of GSK-3β and activating the Wnt/β-catenin signaling pathway. At present, it is unknown whether puerarin ameliorates AD via the Wnt/β-catenin signaling pathway. Therefore, the present study aimed to investigate the role of oligomeric peptide Aβ1-42 in SH-SY5Y cell impairment, and the inhibitory effects of puerarin on tau hyperphosphorylation via the Wnt/β-catenin pathway. Materials and methods Drugs and reagents. The SH-SY5Y human neuroblastoma cell line was obtained from the Chinese Academy of Sciences, Kunming Cell Biological Research Institute (Kunming, Puerarin inhibits β‐amyloid peptide 1‐42‐induced tau hyperphosphorylation via the Wnt/β‐catenin signaling pathway YING YAO1, XIANCHUN CHEN2, YUTING BAO3 and YANGSHENG WU3 1Department of Pharmacy, Hangzhou Medical College, Hangzhou, Zhejiang 310053; 2Department of Pharmacy, Zhejiang University Hospital, Hangzhou, Zhejiang 310012; 3Department of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China Received September 29, 2016; Accepted July 18, 2017 DOI: 10.3892/mmr.2017.7702 Correspondence to: Dr Ying Yao, Department of Pharmacy, Hangzhou Medical College, 481 Binwen Road, Hangzhou, Zhejiang 310053, P.R. China E-mail: realghost1978@163.com
Medicine